Sti

Flere værktøjer



    Registreredes profil

Pfizer Inc.

Identifikationsnummer i registret: 4263301811-33
Registreringsdato: 18/12/2008 10:25:52

Oplysningerne om denne enhed blev senest ændret den: 03/12/2014 13:55:25
Seneste årlige opdatering: 21/11/2014 16:27:28

Dette felt følger formatet fra det tidligere register. Det vil blive ændret til det nye format, når enheden foretager den næste ajourføring.
Næste ajourføring skal senest ske den: 27/04/2015

    Registrerede: Organisation eller selvstændig

Pfizer Inc.

PFE

Corporation

    Kategori

II – Internt ansatte lobbyister og brancheforeninger

Virksomheder og koncerner

    Kontaktoplysninger

East 42nd Street, 235
NY 10017 New York
AMERIKAS FORENEDE STATER

(+1) 2127332323

(+) 

Contact details of Brussels office:

Pfizer European Government Affairs
Boulevard de la Plaine/Pleinlaan 17,
B-1050 Brussels

Tel: +32 2 554 62 11
Fax: +32 2 554 66 60

    Juridisk ansvarlig

Ian C. Read

CEO

    Person med ansvar for forbindelser med EU

Eva Grut-Aandahl

Head of EU Office

    Mål og opgaver

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. In 2012, Pfizer's revenue was 59bn, with approx. 4.5 bn invested in research and development.To learn more, please visit us at www.pfizer.com.

verdensplan

    Aktiviteter

Pharmaceuticals, healthcare, innovation and research, intellectual property, business competitiveness, trade, environment

    Antal personer, der deltager i de aktiviteter, der er beskrevet i feltet ovenfor

6

5 colleagues are full-time engaged in the Brussels office and will spend approx. 75% of their time on EU affairs = 4,25FTE. The number below also include others (15) who may only spend a fraction of their time (between 5%-10%)=approx. 1,5FTE

    Personer akkrediteret ved Europa-Parlamentet

Fornavn Efternavn Startdato Slutdato
Matthew Thomas CLAY 09/01/2015 07/01/2016

    Interesseområder

  • Det indre marked
  • Eksterne forbindelser
  • Erhverv
  • Folkesundhed
  • Forbrugere
  • Forskning og teknologi
  • Generelle og institutionelle spørgsmål
  • Handel
  • Humanitær bistand
  • Konkurrence
  • Miljø
  • Økonomi og finans
  • Retlige Anliggender og grundlæggende rettigheder
  • Told
  • Udvidelse

    Medlemskab og tilhørsforhold

Pfizer is a member of: EFPIA, EBE, Vaccines Europe, EuropaBio, AESGP, Amcham EU, BusinessEurope, TPN, TABC

    Finansielle oplysninger

11/2013  -  11/2014

>= 700.000  € og < 800.000  €

0 €

0 €

This estimate is based on the pro rata salary costs of Pfizer staff involved in interest representation to the European institutions, based on the proportion of employee time spent on these activities. A proportion of overheads for our Brussels office is included in the estimate on the same basis, as well as other costs required in the November 2014 guideline.

    Adfærdskodeks

Organisationen har ved registrering accepteret åbenhedsregistrets adfærdskodeks.

Organisationen har desuden oplyst at være bundet af følgende kodeks:
Internal Pfizer FCPA Code and Compliance, EFPIA Codes